青菜567 发表于 2024-3-19 16:56:54

临床试验重点项目合集(全癌种,全靶点)

本帖最后由 青菜567 于 2024-3-22 09:32 编辑

肺癌:
20ins:
BAY 2927088溶液招募非小细胞肺癌患者(20ins,HER2)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=117180

伏美替尼招募经治肺癌患者(20ins)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121705

伏美替尼招募初治肺癌患者(20ins)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121706

YK-029A片招募非小细胞肺癌患者(20ins)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=117097

KRAS G12C:
JMKX001899片招募非小细胞肺癌患者(KRAS G12C)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=117223

ALK:
CT-3505胶囊招募经治非小细胞肺癌患者(ALK)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=112478

AL2846胶囊招募非小细胞肺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121758

RET:
SY5007招募经治肺癌患者(RET)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121707

SY5007招募初治肺癌患者(RET)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121709

HS-10365招募初治肺癌患者(RET)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121710

MET:
赛沃替尼招募非小细胞肺癌患者(MET)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=116963


乳腺癌:MRG002招募乳腺癌患者(HER2)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=113410

D-0502片招募乳腺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121754

AZD9833片招募乳腺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121759

ARV-471(PF-07850327 )片 招募乳腺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121760

SKB264招募乳腺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121762

DS-1062a招募三阴乳腺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121770

DP303c招募乳腺癌患者(HER2)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121771


卵巢癌:
AZD5305招募卵巢癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121750

IN10018片招募卵巢癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121751


肠癌:

KRAS G12C:D1553招募肠癌患者(KRAS G12C)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121703
CART招募结直肠癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121739
TL938招募肠癌患者(HER2)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121741
LBL-007注射液招募结直肠癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121755
D1553招募经治结直肠癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121761
JMT101招募结直肠癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121765


子宫内膜癌:

HER2:DB1303招募经治子宫内膜癌患者(HER2)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121702

胃癌:
MET:赛沃替尼招募经治胃癌患者(MET)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121723
CART招募晚期胃/食管胃结合部腺癌多线患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121748

注射用ZW25招募胃癌患者(HER2)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121749

Bemarituzumab注射液招募胃癌患者(FGFR)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121756
ASKB589注射液招募胃癌患者(CLDN18.2)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=112208
Bemarituzumab注射液招募胃癌患者(FGFR)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121768
AZD0901招募胃癌患者(Claudin 18.2)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121769

肝胆胰:FGFR:HMPL-453招募晚期肝内胆管癌患者(FGFR)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=111738

ABSK-011招募肝癌患者(FGF19)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=113905

ABSK011招募经治肝癌患者(FGF19,FGFR4)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121724

SYHX2005招募晚期肝细胞癌患者(FGF19)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121729

注射用TFX05-01招募胆管癌、胆囊癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121744


泌尿:
前列腺:达罗他胺片招募前列腺癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=114228

肾癌:
呋喹替尼胶囊招募肾癌患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121752

LOXO-435片招募尿路上皮癌患者(FGFR)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121763


实体瘤:
HG030片招募实体瘤患者(NTRK\ROS1)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=117800

ICP-723招募晚期实体瘤患者(NTRK)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121731

TL118胶囊招募实体瘤患者(NTRK)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=113816

VC004招募晚期实体瘤患者(NTRK)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121743

JYP0322片招募实体瘤患者(ROS1)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121738

ZV0203(ADC药物)招募实体瘤患者(HER2阳性)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=114069

HS-10365招募晚期实体瘤患者(RET)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=114383

ABSK061招募晚期实体瘤患者(FGFR2/3)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121742

SH009注射液招募实体瘤患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121745

HMPL-415S1胶囊招募实体瘤患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121747

ABSK043招募实体瘤患者(PD1)https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121772

骨髓瘤患者:Teclistamab Injection招募多发性骨髓瘤患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=121766

间皮瘤:CAR-T细胞治疗招募间皮瘤患者https://www.yuaigongwu.com/forum.php?mod=viewthread&tid=115057



页: [1]
查看完整版本: 临床试验重点项目合集(全癌种,全靶点)